8-(3-methyl-1-benzofuran-5-yl)-N-[(1S)-1-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]quinoxalin-6-amine
C29H25N5O — CID 122688984
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-(3-methyl-1-benzofuran-5-yl)-N-[(1S)-1-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]quinoxalin-6-amine
8-(3-methyl-1-benzofuran-5-yl)-N-[(1S)-1-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]quinoxalin-6-amine (PubChem CID 122688984) has the molecular formula C29H25N5O and a molecular weight of 459.55 g/mol. Its IUPAC name is 8-(3-methyl-1-benzofuran-5-yl)-N-[(1S)-1-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]quinoxalin-6-amine.
Molecular Properties
| Compound Name | 8-(3-methyl-1-benzofuran-5-yl)-N-[(1S)-1-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]quinoxalin-6-amine |
|---|---|
| PubChem CID | 122688984 |
| Molecular Formula | C29H25N5O |
| Molecular Weight | 459.55 g/mol |
| Exact Mass | 459.21 |
| IUPAC Name | 8-(3-methyl-1-benzofuran-5-yl)-N-[(1S)-1-[3-(1-methylpyrazol-4-yl)phenyl]ethyl]quinoxalin-6-amine |
| SMILES | Cc1coc2ccc(-c3cc(N[C@@H](C)c4cccc(-c5cnn(C)c5)c4)cc4nccnc34)cc12 |
| InChI | InChI=1S/C29H25N5O/c1-18-17-35-28-8-7-22(12-25(18)28)26-13-24(14-27-29(26)31-10-9-30-27)33-19(2)20-5-4-6-21(11-20)23-15-32-34(3)16-23/h4-17,19,33H,1-3H3/t19-/m0/s1 |
| InChIKey | IAMOZDULEPSGQX-IBGZPJMESA-N |
| XLogP | 6.93 |
| TPSA | 68.77 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 459.55 |
| LogP ≤ 5 | 6.93 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122688984 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.